Plain-English translation of NCT07499661 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether doctors should routinely screen all patients admitted to the hospital with acute heart failure for pulmonary embolism—a potentially life-threatening blood clot in the lungs. The study compares two approaches: some hospitals will screen all eligible heart failure patients systematically, while others will continue with their usual practice of deciding case-by-case. Researchers want to find out if systematic screening catches more blood clots and improves patient outcomes.
Doctors suspect that blood clots in the lungs are often missed in patients who come to the hospital with heart failure symptoms, because both conditions cause similar signs like shortness of breath. If a blood clot goes undetected, it can be dangerous or even fatal, so this study aims to determine whether routinely checking for this condition could save lives.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be admitted to the hospital as usual for your heart failure symptoms. Depending on which hospital you're at, you may receive routine blood clot screening tests (such as imaging of your lungs), or doctors will decide on a case-by-case basis whether to perform such tests. The study team will collect information about your symptoms, test results, and treatment throughout your hospital stay and will contact you for follow-up information over the next 90 days.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
France